Oncolytics Biotech Inc (ONCY) stock
ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.44+0.06 (+15.11%)
Close on Nov 18, 2026Market cap $56.14MP/E –Yield –
Oncolytics Biotech revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2021 it was C$0. The highest annual figure on record is C$6.18M in fiscal 2017.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | C$0 | – |
| FY2020 | Dec 31, 2020 | C$0 | – |
| FY2019 | Dec 31, 2019 | C$0 | -100.0% |
| FY2018 | Dec 31, 2018 | C$547.71K | -91.1% |
| FY2017 | Dec 31, 2017 | C$6.18M | – |
See a number that looks wrong?